McIlrath & Eck’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.9K Hold
500
﹤0.01% 863
2025
Q4
$9.94K Hold
500
﹤0.01% 654
2025
Q3
$9.13K Hold
500
﹤0.01% 646
2025
Q2
$7.88K Hold
500
﹤0.01% 638
2025
Q1
$6.34K Hold
500
﹤0.01% 680
2024
Q4
$11K Hold
500
﹤0.01% 603
2024
Q3
$8.91K Buy
+500
New +$8.01K ﹤0.01% 643
2024
Q2
Sell
-500
Closed -$7.43K 958
2024
Q1
$7.43K Hold
500
﹤0.01% 651
2023
Q4
$8.94K Sell
500
-200
-29% -$3.24K ﹤0.01% 584
2023
Q3
$13.4K Buy
+700
New +$12.1K ﹤0.01% 483

Other funds holding CLMT

McIlrath & Eck's CLMT Position: Q1 2026 in Review

McIlrath & Eck held its Calumet Specialty Products (CLMT) position steady in Q1 2026 at 500 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #863.

McIlrath & Eck first reported a position in CLMT in Q3 2023 and has held it in 10 quarters since. 180 funds tracked by Wall St. Rank hold CLMT as of Q1 2026.

  • McIlrath & Eck held 500 shares of Calumet Specialty Products worth $17.9K as of Q1 2026.
  • McIlrath & Eck left its Calumet Specialty Products share count unchanged in Q1 2026.
  • Calumet Specialty Products made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #863 holding.
  • McIlrath & Eck first reported a position in Calumet Specialty Products in Q3 2023 and has held it in 10 quarters since.
  • 180 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.